Primary and combined resistance to four antimicrobial agents in Helicobater pylori in Sofia, Bulgaria

Journal of Medical Microbiology

Volumn 49, Issue 5, 2000, Pages 415-418

  Boyanova, Ludmila ^d   Stancheva, Irina ^a   Spassova, Zoya ^b   Katzarov, Nikolai ^b   Mitov, Ivan ^d   Koumanova, Radka ^c  

^a Department of Gastroenterology   (Bulgaria)

^b UNIVERSITY HOSPITAL ST IVAN RILSKI   (Bulgaria)

^c University Paediatric Hospital   (Bulgaria)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; ANTIINFECTIVE AGENT; CIPROFLOXACIN; CLARITHROMYCIN; ERYTHROMYCIN; MACROLIDE; METRONIDAZOLE; TETRACYCLINE;

ADOLESCENT; ADULT; AGAR GEL DIFFUSION; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; BULGARIA; CHILD; CONTROLLED STUDY; FEMALE; GROWTH INHIBITION; HEALTH SURVEY; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; SCREENING TEST; STRAIN DIFFERENCE;

EID: 0034069486     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-49-5-415     Document Type: Article

References (20)

1. 1. Marshall BJ. Helicobacter pylori. Am J Gastroenterol 1994; 89 8 Suppl: S116-S128.
2. 2. Adamek RJ, Suerbaum S, Pfaffenbach B, Opferkuch W. Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole, and amoxicillin - influence on treatment outcome Am J Gastoenterol 1998; 93: 386-389.
3. 3. Mégraud F. Resistance of Helicobacter pylori to antibiotics. Aliment Pharmacol Ther 1997; 11 Suppl 1: 43-53.
4. 4. Mégraud F. Helicobacter pylori resistance to antibiotics. In: Hunt RH, Tytgat GNJ (eds) Helicobacter pylori: basic mechanisms to clinical cure. Dordrecht, Kluwer Academic. 1994: 570-583.
5. 5. van Zwet AA, de Boer WA, Schneeberger PM, Weel J, Jansz AR, Thijs JC. Prevalence of primary Helicobacter pylori resistance to metronidazole and clarithromycin in the Netherlands. Eur J Clin Microbiol Infect Dis 1996; 15: 861-864.
6. 6. Tillenburg B, Siehoff S, Becker T, Peitz U, Borsch G, Labenz J. [Helicobacter pylori: therapeutic resistance status in Germany (Ruhr area).] Helicobacter pylori: pretherapeutishe resistenzlage in Deutschland (Ruhrgebiet). Z. Gastroenterol 1997; 35: 165-169.
7. 7. Piccolomini R, di Bonaventura G, Catamo G, Carbone F, Neri M. Comparative evaluation of the E test, agar dilution, and broth microdilution for testing susceptibilities of Helicobacter pylori strains to 20 antimicrobial agents. J Clin Microbiol 1997; 35: 1842-1846.
8. 8. Canton R, de Rafael L, Boixeda D, Serano MT. Garcia-Gonzalez M, Baquero F. In vivo acquired resistance to fluoroquinolones in Helicobacter pylori during therapy with ciprofloxacin alone or ciprofloxacin plus amoxycillin clavulanate. In: Pajares JM, Pena AS, Malfertheiner P (eds) H. pylori and gastroduodenal pathology. Berlin, Springer-Verlag. 1993: 305-311.
9. 9. Mégraud F. Antibiotic resistance in Helicobacter pylori infection. In: Farthing MJG, Patchett SE (eds) Helicobacter infection. Br Med Bull 1998; 54: 207-216.
10. 10. Hartzen SH, Andersen LP, Bremmelgaard A et al. Antimicrobial susceptibility testing of 230 Helicobacter pylori strains: importance of medium, inoculum, and incubation time. Antimicrob Agents Chemother 1997; 41: 2634-2639.
11. 11. Boyanova L, Stancheva I, Todorov D et al. Comparison of three urease tests for detection of Helicobacter pylori in gastric biopsy specimens. Eur J Gastroenterol Hepatol 1996; 8: 911-914.
12. 12. Fauchère JL. Validation of a disk diffusion method for macrolide susceptibility testing of Helicobacter pylori. Gut 1999; 45 Suppl 111: A9.
13. 13. Chaves S, Gadanho M, Tenreiro R, Cabrita J. Assessment of metronidazole susceptibility in Helicobacter pylori: statistical validation and error rate analysis of breakpoints determined by the disk diffusion method. J Clin Microbiol 1999; 37: 1628-1631.
14. 14. Midolo PD, Turnidge J, Lambert JR, Bell JM. Validation of a modified Kirby-Bauer disk diffusion method for metronidazole susceptibility testing of Helicobacter pylori. Diagn Microbiol Inject Dis 1995; 21: 135-140.
15. 15. Xia H, Keane CT, Beattie S, O'Morain CA. Standardization of disk diffusion test and its clinical significance for susceptibility testing of metronidazole against Helicobacter pylori. Antimicrob Agents Chemother 1994, 38: 2357-2361.
16. 16. Glupczynski Y, van der Borre C, Devaster JM, Butzler JP. Evaluation of metronidazole and clarithromycin screening agar plates for in vitro susceptibility testing of H. pylori. Clin Microbiol Infect 1997; 3 Suppl 2: 232.
17. 17. National Committee for Clinical Laboratory Standards. Methods for antimicrobial susceptibility testing of anaerobic bacteria, 3rd edn. Approved standard M11-A3. Villanova, PA, NCCLS. 1993.
18. 18. Solnick JV. Editoral response: antibiotic resistance in Helicobacter pylori. Clin Infect Dis 1998; 27: 90-92.
19. 19. Carbone M, Ferra MT, Cecchetti V et al. In vitro activities of new quinolones against Helicobacter pylori. Antimicrob Agents Chemother 1997; 41: 2790-2792.
20. 20 Nakae M, Sugahara J, Sasaki H et al. [Drug-susceptibility of clinically isolated Helicobacter pylori.] Jpn J Antibiot 1998; 51: 281-285.